BioNTech SE - ADR vs Dollar Tree, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Dollar Tree, Inc. trades at $128.1 (market cap $24.61B). The key difference: BioNTech SE - ADR and Dollar Tree, Inc. are close in size by market cap, and Dollar Tree, Inc. is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | DLTR | |
|---|---|---|
Market Cap | $23.31B | $24.61B |
Sector | Health | Health |
52-Week High | $119.34 | $141.21 |
52-Week Low | $83.89 | $85.04 |
Enterprise Value | $6.60B | $31.20B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.
Read more on DLTR →